GOLDMAN SACHS GROUP INC - ACADIA PHARMACEUTICALS INC ownership

ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 249 filers reported holding ACADIA PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.57 and the average weighting 0.1%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of ACADIA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$14,976,145
-50.9%
718,625
-43.6%
0.00%
-50.0%
Q2 2023$30,498,505
+65.4%
1,273,424
+30.0%
0.01%
+50.0%
Q1 2023$18,438,669
+16.9%
979,738
-1.1%
0.00%0.0%
Q4 2022$15,770,718
-18.3%
990,623
-16.1%
0.00%0.0%
Q3 2022$19,311,000
+29.6%
1,180,398
+11.6%
0.00%
+33.3%
Q2 2022$14,900,000
-44.3%
1,057,494
-4.2%
0.00%
-50.0%
Q1 2022$26,748,000
-3.0%
1,104,377
-6.6%
0.01%
+20.0%
Q4 2021$27,586,000
+100.9%
1,181,923
+42.9%
0.01%
+66.7%
Q3 2021$13,734,000
+0.3%
826,846
+47.3%
0.00%0.0%
Q2 2021$13,690,000
-49.1%
561,315
-46.1%
0.00%
-57.1%
Q1 2021$26,890,000
-50.4%
1,042,249
+2.7%
0.01%
-50.0%
Q4 2020$54,267,000
+28.2%
1,015,090
-1.1%
0.01%
+27.3%
Q3 2020$42,321,000
-23.7%
1,025,967
-10.4%
0.01%
-31.2%
Q2 2020$55,476,000
-10.7%
1,144,546
-22.2%
0.02%
-27.3%
Q1 2020$62,149,000
+15.9%
1,470,977
+17.3%
0.02%
+57.1%
Q4 2019$53,627,000
+19.1%
1,253,557
+0.2%
0.01%
+7.7%
Q3 2019$45,037,000
+3.4%
1,251,376
-23.2%
0.01%0.0%
Q2 2019$43,542,000
-16.7%
1,628,987
-16.3%
0.01%
-18.8%
Q1 2019$52,246,000
+33.1%
1,945,845
-19.8%
0.02%
+33.3%
Q4 2018$39,250,000
+39.7%
2,427,312
+79.4%
0.01%
+71.4%
Q3 2018$28,095,000
+121.4%
1,353,307
+62.9%
0.01%
+133.3%
Q2 2018$12,689,000
-56.0%
830,983
-35.2%
0.00%
-57.1%
Q1 2018$28,830,000
-19.6%
1,283,046
+7.7%
0.01%
-22.2%
Q4 2017$35,859,000
-50.4%
1,190,924
-38.0%
0.01%
-47.1%
Q3 2017$72,338,000
+35.9%
1,920,278
+0.6%
0.02%
+21.4%
Q2 2017$53,222,000
+37.9%
1,908,251
+69.9%
0.01%
+40.0%
Q1 2017$38,605,000
-16.8%
1,122,899
-30.2%
0.01%
-28.6%
Q4 2016$46,382,000
+14.0%
1,608,258
+25.7%
0.01%
+16.7%
Q3 2016$40,691,000
+255.8%
1,279,191
+263.0%
0.01%
+200.0%
Q2 2016$11,437,000
-47.0%
352,361
-54.4%
0.00%
-50.0%
Q1 2016$21,593,000
+171.8%
772,268
+246.7%
0.01%
+166.7%
Q4 2015$7,943,000
+27.4%
222,779
+18.2%
0.00%0.0%
Q3 2015$6,234,000
-44.5%
188,487
-29.7%
0.00%0.0%
Q2 2015$11,223,000
+18.9%
267,986
-7.5%
0.00%
-25.0%
Q1 2015$9,441,000
-79.5%
289,682
-80.0%
0.00%
-71.4%
Q4 2014$46,088,000
-44.9%
1,451,612
-57.1%
0.01%
-48.1%
Q3 2014$83,694,000
+4.4%
3,380,225
-4.8%
0.03%
+8.0%
Q2 2014$80,178,000
-4.4%
3,549,247
+3.0%
0.02%
-7.4%
Q1 2014$83,857,000
-13.1%
3,446,680
-10.7%
0.03%
-15.6%
Q4 2013$96,497,000
-7.8%
3,861,430
+1.3%
0.03%
-17.9%
Q3 2013$104,674,000
+28.8%
3,810,477
-14.9%
0.04%
+25.8%
Q2 2013$81,300,000
+608.3%
4,479,347
+81.5%
0.03%
+675.0%
Q4 2012$11,478,0002,468,2990.00%
Other shareholders
ACADIA PHARMACEUTICALS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Finepoint Capital LP 556,553$11,598,5655.78%
Baker Brothers Advisors 42,864,612$893,298,5145.15%
RTW INVESTMENTS, LP 11,576,537$241,255,0315.09%
Palo Alto Investors LP 2,405,793$50,136,7264.74%
Birchview Capital, LP 240,400$5,009,9364.26%
EcoR1 Capital, LLC 5,991,479$124,862,4224.21%
EMERALD ADVISERS, LLC 1,681,052$35,033,1241.70%
EMERALD MUTUAL FUND ADVISERS TRUST 1,303,988$27,175,1101.64%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 179,702$3,739,5991.26%
SECTOR GAMMA AS 179,785$3,746,7190.96%
View complete list of ACADIA PHARMACEUTICALS INC shareholders